Ccl21b



Ccl21b

M1MM1A2AA2Q3QQ3M4MM4M5MM5T6TT6L7LL7S8SS8L9LL9L10LL10S11SS11L12LL12V13VV13L14LL14A15AA15L16LL16C17CC17I18II18P19PP19W20WW20T21TT21Q22QQ22G23GG23S24SS24D25DD25G26GG26G27GG27G28GG28Q29QQ29D30DD30C31CC31C32CC32L33LL33K34KK34Y35YY35S36SS36Q37QQ37K38KK38K39KK39I40II40P41PP41Y42YY42S43SS43I44II44V45VV45R46RR46G47GG47... and 86 more residue(s)...... and 86 more residue(s)

SMILES None
InChIKey None
Sequence MAQMMTLSLLSLVLALCIPWTQGSDGGGQDCCLKYSQKKIPYSIVRGYRKQEPSLGCPIPAILFLPRKHSKPELCANPEEGWVQNLMRRLDQPPAPGKQSPGCRKNRGTSKSGKKGKGSKGCKRTEQTQPSRG

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

Ccl21b

M1MM1A2AA2Q3QQ3M4MM4M5MM5T6TT6L7LL7S8SS8L9LL9L10LL10S11SS11L12LL12V13VV13L14LL14A15AA15L16LL16C17CC17I18II18P19PP19W20WW20T21TT21Q22QQ22G23GG23S24SS24D25DD25G26GG26G27GG27G28GG28Q29QQ29D30DD30C31CC31C32CC32L33LL33K34KK34Y35YY35S36SS36Q37QQ37K38KK38K39KK39I40II40P41PP41Y42YY42S43SS43I44II44V45VV45R46RR46G47GG47... and 86 more residue(s)...... and 86 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.